Ryman Healthcare Ltd. (NZ:RYM)
:RYM
Earnings Data
Report Date
Dec 02, 2026TBA (Confirmed)
Period Ending
2027 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-0.04Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call reported clear operational progress: doubled operating EBITDAF, strong aged-care performance (EBITDAF per bed +31%), significant cost savings ($57m), positive free cash flow of $188m, reduced development exposure and a strengthened balance sheet (refinancing, lower interest costs). Management acknowledges remaining challenges — resale stock and margins, timing of DMF cash benefits, one-off transformation costs, FX effects and regional market competitiveness — and provided targets and actions (sales/marketing investment, land divestments, product changes, and a $150m CFEO improvement target to FY'29). Overall the positives — particularly cash generation, cost-out, and aged care momentum — materially outweigh the current lowlights, supporting a constructive outlook while risks from market conditions and timing remain.Company Guidance
Positive Free Cash Flow
Delivered positive free cash flow of $188 million in FY'26 — the first positive free cash flow in over a decade — driven by robust new sales, moderating development spend and land-bank divestments.
Earnings and Revenue Momentum
Operating revenue increased 10% year-on-year; operating EBITDAF doubled (2x) during the year, reflecting improved recurring earnings and cost discipline.
Aged Care Outperformance
Aged care was the standout segment: second-half EBITDAF grew 32% and EBITDAF per bed lifted 31% to just over $20,000. Country-level EBITDAF reached NZD 15,000 (New Zealand) and ~NZD 32,000 (Australia).
Cash and Balance Sheet Strengthening
Net debt reduced by $94 million to $1.57 billion; completed $2 billion bank refinancing with no maturities until FY'31; $675 million of debt headroom and gearing under 28%.
Substantial Cash Releases and Land Divestments
Delivered $169 million of cash release in FY'26 from land and stock actions, with $147 million contracted land sales (and $72 million cash received). Land divestment target increased toward ~$250 million.
Cost Savings and Efficiency
Achieved $57 million in gross annualized cost savings since FY'24 (top end of $50–$60m guidance); gross non-village costs down 25% and headcount reduced 39% since FY'24, enabling a leaner operating model.
Development Discipline and Reduced CapEx
Active construction sites reduced from 7 to 2, development CapEx fell to $222 million (slightly below guidance of $235m) with estimated committed cost to go of $190 million for remaining main buildings — lowering capital intensity and cycle risk.
Strong Care Demand and Occupancy
Opened 5 new care centres in last 2 years (with only 1 p.a. planned next 3 years); multiple new centres reached ~90% occupancy; premium penetration over 80% in both Australia and New Zealand; revenue per bed up 6% in NZ and 9% in AU.
Product and Pricing Reset in Retirement Living
Contract reset embedded: new deferred management fee (DMF) for new residents averaging 30% and weekly fees for new residents up 63% on unit turnover; 17% of portfolio already on new weekly fees, targeted to be ~50% by FY'29.
Improved Valuations and Lower Financing Costs
Aged care book values per bed increased NZ +11% and AU +16% (6% on constant currency); annualized gross interest costs down $68 million since Feb 2025 and average cost of debt reduced to 5.9% with two-thirds of interest exposure fixed for two years.
NZ:RYM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NZ:RYM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 25, 2026 | $2.19 | $2.22 | +1.37% |
Nov 26, 2025 | $2.86 | $2.92 | +2.10% |
May 29, 2025 | $2.22 | $2.10 | -5.41% |
Nov 27, 2024 | $4.70 | $4.66 | -1.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ryman Healthcare Ltd. (NZ:RYM) report earnings?
Ryman Healthcare Ltd. (NZ:RYM) is schdueled to report earning on Dec 02, 2026, TBA (Confirmed).
What is Ryman Healthcare Ltd. (NZ:RYM) earnings time?
Ryman Healthcare Ltd. (NZ:RYM) earnings time is at Dec 02, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Ryman Healthcare Ltd. stock?
The P/E ratio of Ryman Healthcare is N/A.
What is NZ:RYM EPS forecast?
Currently, no data Available